Austrianova’s room temperature stable Bac-in-a-Box® micro-encapsulated bacteria accelerates grass to grain transition with weight gain and methane reduction. 

SINGAPORE, August 2, 2023/ — Austrianova and ProAgni announced today the signing of a licensing and manufacturing agreement that foresees an intensification of joint activities between the two companies in the area of development and commercialization of shelf stable probiotic additives for cattle feed as well as for other farm animals.

Austrianova, a Singaporean biotech company, has developed its patented Bac-in-a-Box® technology specifically to efficiently protect bacteria from stomach acid as well as to allow storage at room temperature without appreciable loss of viability. ProAgni is a well known livestock feed supplement supplier based in Australia, but also active in the USA, that has rights and access to a number of bacterial strains that are active in the rumen.

“The ability to shelf stabilize ruminal bacteria is a game changer. With the proven advantages of Bac-in-the-Box, we are advancing our innovative lead product to the market together with Austrianova”

— Lachlan Campbell, CEO ProAgni

Bac-in-a-Box® encapsulation of ProAgni’s bacterial strains allows significantly improved storage at room temperature as well as delivery of greater numbers of living bacteria. The storage and enhanced efficacy has been shown in a controlled and independently monitored field trial in cattle.


Full press release can be viewed online at: 





About Austrianova
Austrianova, part of the SG Austria Group, is a biotech company with a global footprint and headquarters in Singapore. Austrianova utilizes a novel and proprietary technology for the encapsulation of living mammalian (Cell-in-a-Box®) and bacterial (Bac-in-a-Box®) cells. Cell-in-a-Box® protects the encapsulated cells from rejection by the immune system, allows cells to be easily transported, stored and implanted at specific sites in patients. The technology, which has been proven safe and efficacious in clinical trials carried out in Europe, allows companies to develop any kind of cells as a one-for-all living pharmaceutical. Bac-in-a-Box® is a similar protective device adapted for encapsulation of probiotic bacteria where it has human food and animal feed applications due to its ability to extend storage under lyophilized conditions and to protect encapsulated bacteria against destruction by stomach acid. Austrianova now also offers GMP4Cells that includes competitively priced Master Cell Bank and Working Cell Bank production as well as “Fill and Finish” services for cell therapy products (such as stem cell therapies, biologics produced from cells e.g. vaccines, antibodies, recombinant proteins etc).


Walter Gunzburg


Visit us on social media: